🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label fixed dose phase Ib of anti-CEA CAR-T cells hepatic a...
Status
Completed
Location
Roger Williams Medical Center
Start Date
2015-04
Trial ID
NCT02416466
Treatments Being Tested
This study is a single-arm, open-label, dose-escalating + dose-expansion cl...
Status
Recruiting
Location
Shanxi Bethune Hospital
Start Date
2023-09-07
Trial ID
NCT06006390
Treatments Being Tested
This trial is an open-label, single-arm clinical study. The main purpose is...
Status
Completed
Location
Shandong Second Provincial General Hospital
Start Date
2021-09-10
Trial ID
NCT05415475
Treatments Being Tested
This study is an open-label, single arm phase 1b safety study of CAR2 Anti-...
Status
Terminated
Location
Roger Williams Medical Center
Start Date
2019-07-29
Trial ID
NCT03818165
Treatments Being Tested
The purpose of this study is to collect the date on the safety and potentia...
Status
Unknown
Location
Shanghai Tumor Hospital
Start Date
2016-07
Trial ID
NCT02959151
Treatments Being Tested
This is a single-center, open-label clinical study of anti-CEA-CAR-T cells ...
Status
Recruiting
Location
The First Affiliated Hospital of China Medical Univeristy
Start Date
2023-10-23
Trial ID
NCT06013111
Treatments Being Tested
This study is a open-label, dose-escalating + dose-expansion clinical study...
Status
Recruiting
Location
The First Affiliated Hospital of Wannan Medical College
Start Date
2023-11-06
Trial ID
NCT06126406
Treatments Being Tested
The main purpose of this research is to verify the safety of CEA targeted c...
Status
Unknown
Location
Southwest Hospital of Third Millitary Medical University
Start Date
2014-12
Trial ID
NCT02349724
Treatments Being Tested
Immunotherapy has become the major breakthrough and the most promising trea...
Status
Unknown
Location
Harbin Medical University
Start Date
2017-06-15
Trial ID
NCT03267173
Treatments Being Tested
This is a phase I clinical study to evaluate the safety and tolerability of...
Status
Completed
Location
First affiliated hospital, Zhejiang University
Start Date
2022-05-25
Trial ID
NCT05396300
Treatments Being Tested